Best hospitals for Oncology: A 2026 international ranking and evaluation guide

What the latest oncology rankings show

For readers researching the best hospitals for Oncology, the 2026 World’s Best Specialized Hospitals oncology ranking places Memorial Sloan Kettering Cancer Center in New York City first, followed by MD Anderson Cancer Center in Houston, Samsung Medical Center in Seoul, Asan Medical Center in Seoul, and Mayo Clinic in Rochester. The ranking includes 300 oncology hospitals and is presented by Newsweek and Statista. 1

The international list is geographically diverse. Gustave Roussy in Villejuif ranks sixth, The Royal Marsden Hospital in London seventh, Seoul National University Hospital eighth, Princess Margaret Cancer Centre in Toronto ninth, and Johns Hopkins Hospital in Baltimore tenth. These positions describe broad institutional standing, not a guaranteed result for an individual diagnosis, treatment plan, or stage of cancer. 1

Leading hospitals in the international top 10

The next five institutions in the Newsweek oncology ranking are Gustave Roussy, The Royal Marsden Hospital, Seoul National University Hospital, Princess Margaret Cancer Centre, and The Johns Hopkins Hospital. Their presence reflects the role of major academic and specialist centers in complex cancer care, research, education, and multidisciplinary treatment. The ranking itself does not identify one hospital as appropriate for every cancer type or every patient. 1

Oncology News Central reported that the 2026 positions reversed the previous year’s ordering of the two leading U.S. centers. It also noted that four American institutions appeared in the international top 10 and that hundreds of additional hospitals were assessed in other medical specialties. Rankings therefore provide a starting point for comparison, while diagnosis-specific expertise remains essential. 2

How U.S. rankings differ from global rankings

International and national rankings can produce different results because they use different methodologies, comparison groups, and publication schedules. The 2026 international oncology list ranks MD Anderson second and Memorial Sloan Kettering first, while U.S. News and World Report’s 2026 to 2027 cancer-care ranking places MD Anderson first nationally and Memorial Sloan Kettering second. MD Anderson has held the U.S. News first position for 12 consecutive years, according to published reports. 3

The U.S. News ranking also lists Dana-Farber Brigham Cancer Center, Mayo Clinic in Rochester, Massachusetts General Hospital, Johns Hopkins Hospital, Hospital of the University of Pennsylvania, Northwestern Memorial Hospital, Stanford Hospital, Mount Sinai Hospital, and UCSF Medical Center among the leading U.S. cancer programs. This illustrates why a hospital’s position should be interpreted within the specific ranking system rather than treated as a universal hierarchy. 3

Clinical research and specialized services

A hospital’s research infrastructure can affect the range of treatment options under clinical investigation. Stephenson Cancer Center is described as Oklahoma’s only National Cancer Institute-designated cancer center, with more than 250 ongoing original biomedical research projects and a position among the nation’s leading centers for participation in NCI-sponsored clinical trials. These figures illustrate how research volume and trial participation can be relevant comparison factors. 6

Other institutions report substantial research activity. Montefiore Einstein Comprehensive Cancer Center states that it treats more than 400 types of cancer and has more than 500 active clinical research studies. UF Health Cancer Institute reports nearly 200 clinical trials, more than $55 million in annual cancer research funding, and 375 members across disciplines. Such figures describe institutional capacity, not a promise that a particular patient qualifies for a study. 5 9

Accreditation and quality factors to examine

The National Cancer Institute designates comprehensive cancer centers that demonstrate strength in laboratory research, population science, and clinical cancer care. Commission on Cancer accreditation identifies programs meeting standards for multidisciplinary care, treatment planning, quality improvement, and patient services. These designations can add context to a ranking because they assess defined institutional capabilities rather than relying only on reputation. 12 14

The Joint Commission offers cancer-care certification programs that evaluate whether hospitals meet specified standards for treatment and patient safety. Public comparison tools such as Medicare Care Compare can provide hospital-level information about quality measures, patient experiences, and other performance indicators. These resources have limitations, so results should be read alongside disease-specific outcomes, clinician expertise, and the hospital’s ability to coordinate surgery, radiation, systemic therapy, and supportive care. 15 16

• NCI designation: research and comprehensive cancer-care capability.
• Commission on Cancer accreditation: multidisciplinary program standards.
• Joint Commission certification: defined cancer-care and safety standards.
• Medicare Care Compare: public quality and patient-experience measures.

Matching a hospital to an individual cancer need

National reputation is only one consideration in selecting an oncology hospital. The relevant comparison may instead involve expertise in a particular tumor type, availability of molecular diagnostics, complex surgery, cellular therapy, radiation technology, pediatric oncology, or treatment for a rare cancer. The supplied research identifies precision oncology, immunotherapy, cellular treatments, and genomic analysis as major areas of change, making subspecialty capability an important practical question. 10

ClinicalTrials.gov provides searchable records for oncology studies, including recruitment status, locations, interventions, sponsors, and eligibility criteria. The National Comprehensive Cancer Network publishes evidence-based oncology guidelines, while the American Cancer Society provides cancer incidence, mortality, survival, and risk-factor statistics. Reviewing these sources can help distinguish institutional prestige from a program’s fit for the diagnosis, treatment goal, travel requirements, and ongoing follow-up needs. 17 18 19

Sources

1. Newsweek, World’s Best Specialized Hospitals 2026, Oncology
2. Oncology News Central, Annual Oncology Hospital Rankings Released
3. Healio, UT MD Anderson ranked nation’s top cancer hospital
4. Memorial Sloan Kettering Cancer Center
5. Montefiore Einstein Comprehensive Cancer Center
6. OU Health Stephenson Cancer Center
7. UCI Health cancer services report
8. The Gilmer Mirror, MD Anderson national ranking report
9. UF Health Cancer Institute
10. Scienmag, MD Anderson national ranking report
11. U.S. News and World Report cancer rankings
12. National Cancer Institute cancer-center designation information
13. American College of Surgeons Commission on Cancer
14. American Cancer Society cancer statistics
15. The Joint Commission cancer-care certification
16. Medicare Care Compare
17. ClinicalTrials.gov
18. National Comprehensive Cancer Network guidelines